Pigmented Basal Cell Carcinomas 15 Years After Orbital Radiation Therapy for Graves Ophthalmopathy

Haenssle, Holger A.; Richter, A. K.; Buhl, Timo; Haas, E; Holzkamp, Ricarda; Emmert, Steffen; Schön, Michael P.

doi:10.1001/archdermatol.2011.74

Cited by 7 publications

(3 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Se ha descrito algún caso excepcional de carcinoma basal pigmentado 68 . El riesgo teórico calculado tras la irradiación retrobulbar con 20 Gy es de 0,3 a 1,2% 69 .…”

Section: Efectos Secundariosunclassified

Orbitopatía tiroidea, una visión global con atención especial al papel de la radioterapia

Vilar-González

Oliveira

Fagúndez-Vargas³

et al. 2015

Endocrinología y Nutrición

View full text Add to dashboard Cite

“…Se ha descrito algún caso excepcional de carcinoma basal pigmentado 68 . El riesgo teórico calculado tras la irradiación retrobulbar con 20 Gy es de 0,3 a 1,2% 69 .…”

Section: Efectos Secundariosunclassified

Orbitopatía tiroidea, una visión global con atención especial al papel de la radioterapia

Vilar-González

Oliveira

Fagúndez-Vargas³

et al. 2015

Endocrinología y Nutrición

View full text Add to dashboard Cite

“…Mortality has obtained similarly in the irradiated and nonirradiated patients [225]. Haenssle et al reported pigmented basal cell carcinomas 15 years after orbital RT therapy for TAO [226]. The long-term treatment results seem to be satisfactory.…”

Section: Radiotherapymentioning

confidence: 99%

Complications of Hyperthyroidism

Sayin¹,

Ertek²,

Cesur³

2014

Thyroid Disorders - Focus on Hyperthyroidism

View full text Add to dashboard Cite

“…The contraindications of RT include inactive stages of TAO, patients younger than 35 years of age due to a theoretical risk and poorly controlled diabetes. The most serious side effect is the development of secondary malignancy, namely meningioma or pigmented basal cell carcinoma 13,14 . However long-term follow-up has not revealed a high incidence of radiation induced secondary tumors 15 .…”

Section: Introductionmentioning

confidence: 99%

Clinical Results of Combined Systemic Steroid and Retroorbital Radiotherapy Treatment in Active Thyroid Associated Ophthalmopathy

et al. 2023

View full text Add to dashboard Cite

Objective: The aim of this study is to evaluate the efficacy of a different steroid dosage protocol which consists of intravenous pulse methylprednisolone combined with retroorbital radiotherapy in the treatment of active thyroid associated ophthalmopathy. Methods: The medical records of 29 patients who were treated with a standard protocol and who were followed-up for at least 6 months were retrospectively analyzed. The treatment protocol consisted of intravenous pulse methylprednisolone 1gram/day for 3 consecutive days, followed by retroorbital radiotherapy. Oral prednisolone which was tapered over a 3-month course was given as a maintenance dose. Results: 58 eyes of 29 patients were included in the study. Twelve patients were female (41%) and 17 were male (59%) with a mean age of 47.7 ± 12.6 years. The clinical activity score was 4.8 ± 1.3 and 2.8 ± 1.2, before and after treatment, respectively (P

show abstract

Pigmented Basal Cell Carcinomas 15 Years After Orbital Radiation Therapy for Graves Ophthalmopathy

Cited by 7 publications

References 5 publications

Orbitopatía tiroidea, una visión global con atención especial al papel de la radioterapia

Orbitopatía tiroidea, una visión global con atención especial al papel de la radioterapia

Complications of Hyperthyroidism

Clinical Results of Combined Systemic Steroid and Retroorbital Radiotherapy Treatment in Active Thyroid Associated Ophthalmopathy

Contact Info

Product

Resources

About